901 related articles for article (PubMed ID: 22155902)
1. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
2. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
3. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
4. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
Arévalo MT; Simpson-Haidaris PJ; Kou Z; Schlesinger JJ; Jin X
J Med Virol; 2009 Mar; 81(3):519-28. PubMed ID: 19152413
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
6. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
Zou G; Xu HY; Qing M; Wang QY; Shi PY
Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
[TBL] [Abstract][Full Text] [Related]
9. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
12. Interference in dengue virus adsorption and uncoating by carrageenans.
Talarico LB; Damonte EB
Virology; 2007 Jul; 363(2):473-85. PubMed ID: 17337028
[TBL] [Abstract][Full Text] [Related]
13. Infection of Aedes albopictus Mosquito C6/36 Cells with the
Teramoto T; Huang X; Armbruster PA; Padmanabhan R
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
[TBL] [Abstract][Full Text] [Related]
16. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
[TBL] [Abstract][Full Text] [Related]
17. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
[TBL] [Abstract][Full Text] [Related]
18. Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A.
Nobori H; Toba S; Yoshida R; Hall WW; Orba Y; Sawa H; Sato A
Antiviral Res; 2018 Jul; 155():60-66. PubMed ID: 29758236
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of doxycycline against dengue virus replication in vitro.
Rothan HA; Mohamed Z; Paydar M; Rahman NA; Yusof R
Arch Virol; 2014 Apr; 159(4):711-8. PubMed ID: 24142271
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]